MOXIFLOXACIN hydrochloride, eq 400mg base, tab. blister
STD
DORAMOXI4T1
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
07/11/2024, 18:45:09
Former
Code(s):
DORAMOXI4T- DORAZFR0539
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01MA14
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
MOXIFLOXACIN
- In the WHO list of Essential Medicines 2023 (Complementary List)
Therapeutic Action
Fluoroquinolone antibacterical
Moxifloxacin and levofloxacin belong to the same therapeutic group.
Indications
Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
The 100 mg dispersible tablet is intended for paediatric use. To be dispersed in 10 ml water.
Must be taken 2 hours apart from milk-based product, antiacids, calcium, iron and zinc salts.
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25ºC - Protect from sunlight- Protect from humidity